Clinical trial · Observational
Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal Carcinoma
NCT05794737CI-TRIAL-00065235unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A retrospective observational study to evaluate immunohistochemical expression of Inhibin Beta A (INHBA) in 60 cases of Colorectal Carcinoma, and compare levels of its expression to different clinicopathological criteria.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Immunohistochemical staining | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Participants
- description
- 60 archived Formalin-fixed Paraffin-embedded tissue blocks of Colorectal Carcinoma will be obtained and sectioned. From each block; Two tissue sections will be prepared, one tissue section will be stained by Hematoxylin and Eosin to detect tumor phenotype and depth of invasion. Other tissue section will be immunohistochemically stained by Anti-Human INHBA.
- interventionNames
- Biological: Immunohistochemical staining
Primary outcomes (1)
- measure
- Detection of INHBA in Colorectal Carcinoma.
- timeFrame
- 6 months
- description
- Detection of expression of INHBA in Colorectal Carcinoma cells by immunohistochemical approach, using anti-human INHBA monoclonal antibody.
Secondary outcomes (1)
- measure
- Correlation between INHBA expression in Colorectal Carcinoma and clinicopathological parameters.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 35 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: Specimens from patients with Colorectal Carcinoma. Tissue blocks with sufficient material. Specimens with sufficient clinical data. Exclusion Criteria: Tissue blocks with insufficient, destroyed or necrotic material. Specimens with insufficient clinical data.
References
Publications (0)
Data not yet available
No reference posted for this study.